THE FUTURE OF CARE
Provide remote guidance with the first hormone measurement tool that captures qualitative hormone readings in real-time, through an at-home urine test.
Track your patients' data on a HIPAA compliant dashboard, and send personalized recommendations to patients through the Oova app.
With the first urine test that measures LH and progesterone, Oova reports precise results in real time on the provider dashboard and patient app — so no one ever misses a fertile window or is stuck anxiously waiting.
MORE FERTILITY ANSWERS FROM DAY 1
Learn more about patients from the start—from cycle length, to egg release patterns, to potential issues—regardless of regularity. This enables you to give personalized care and focus your testing.
EFFECTIVE, NON-INVASIVE TREATMENT
Fertility is elusive for many, but it doesn't have to be. Oova's hyper-transparent insights allow patients to confidently transition to IVF; no more unnecessary in-clinic samples and painstaking frustration.
Capturing accurate, quantified hormone data every day, Oova removes the subjectivity of traditional tests and trackers. View alongside patient inputs for a full fertility health picture.
Oova analyzes cycle trends over time and supplies deep insight, identifying fertile windows, egg release, period, and more for providers to track progress.
Recommendations for additional treatment and diagnostics, and the ability to message patients directly make personalized guidance easy.
As parent-hopefuls and fertility professionals alike, we experienced the need for accessible, accurate testing, and the strain of unreliable consumer products. So we invested years of R&D to launch a lab-quality solution—enabling providers to be in true harmony with their patients for the first time ever.Dr. Aparna (Amy) Divaraniya,CEO & FOUNDERJerome Scelza,FOUNDERBacked by Mount Sinai Hospital
Monitoring hormone levels in individuals affected by infertility remains the standard of care for ensuring proper management of the condition. Typically, Luteinizing Hormone (LH) is tested, and a positive or negative result is conveyed using a threshold-based test. Upon a positive result, the patient believes they are ovulating. Similarly, pregnanediol-3 (PdG) is tested to confirm the release of an egg.
Unfortunately, due to the poor sensitivity and dynamic range of traditional, lateral flow based immunoassays, these tests provide very little insight. These tests are designed to work at predetermined thresholds and, therefore, often mislead a woman who does not fit this average profile.
Read Our Research
If you would like more information on Oova's technology, please fill out this form and we will email you a collection of our research papers and studies.
If you would like more information on how to become an Oova Provider, please fill out this form and a representative from our team will be in touch soon.